Citation Impact
Citing Papers
Functional specialization of β-arrestin interactions revealed by proteomic analysis
2007 StandoutNobel
CD151 Accelerates Breast Cancer by Regulating α6 Integrin Function, Signaling, and Molecular Organization
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Urokinase Plasminogen Activator Is Immunocytochemically Detectable in Squamous Cell but Not Basal Cell Carcinomas
1992
Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes
2011 Standout
Sphingosine 1-Phosphate Activates Akt, Nitric Oxide Production, and Chemotaxis through a GiProtein/Phosphoinositide 3-Kinase Pathway in Endothelial Cells
2001
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
2005 StandoutNobel
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis
2006
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
2008 StandoutNature
Rb Regulates Interactions between Hematopoietic Stem Cells and Their Bone Marrow Microenvironment
2007
Invasion of the trophoblasts
1992
Prostate‐specific antigen activates single‐chain urokinase‐type plasminogen activator
1995
Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
1995
Forces in Tissue Morphogenesis and Patterning
2013 Standout
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1
2001
Cancer Metastasis: Building a Framework
2006 Standout
RAS oncogenes: weaving a tumorigenic web
2011
Imaging in the era of molecular oncology
2008 StandoutNature
Lung Cancer
2008 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle
2004
Proteomic profiling identifies breast tumor metastasis‐associated factors in an isogenic model
2007
MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes
1998 Standout
Biomimetic proteolipid vesicles for targeting inflamed tissues
2016
Comprehensive proteomics in yeast using chromatographic fractionation, gas phase fractionation, protein gel electrophoresis, and isoelectric focusing
2005
Molecular Events Mediating T Cell Activation
1990
Antibody targeted drugs as cancer therapeutics
2006
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Pathophysiology of Premature Skin Aging Induced by Ultraviolet Light
1997 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Diabetic Retinopathy
2012 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Aptamer Directly Evolved from Live Cells Recognizes Membrane Bound Immunoglobin Heavy Mu Chain in Burkitt's Lymphoma Cells
2007
The microenvironment of the tumour–host interface
2001 StandoutNature
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Quantitative Membrane Proteomics Reveals New Cellular Targets of Viral Immune Modulators
2006
In Vivo Imaging of Molecularly Targeted Phage
2006
Suppression of inflammation by a synthetic histone mimic
2010 StandoutNatureNobel
Mass spectrometry in high-throughput proteomics: ready for the big time
2010
Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues
1991
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas
1993
Mechanisms of Bone Metastasis
2004 Standout
Endothelium-Microenvironment Interactions in the Developing Embryo and in the Adult
2007
Insight into nanoparticle cellular uptake and intracellular targeting
2014
A matrix metalloproteinase expressed on the surface of invasive tumour cells
1994 StandoutNature
Calcium Signaling
2007 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Reassessment of Exosome Composition
2019 Standout
Endocytosis of nanomedicines
2010 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-α induced apoptosis
1998
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
TRPV3 regulates nitric oxide synthase-independent nitric oxide synthesis in the skin
2011 StandoutNobel
Vascular permeability, vascular hyperpermeability and angiogenesis
2008
Annexins: linking Ca2+ signalling to membrane dynamics
2005
Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents
2009
Bovine urokinase-type plasminogen activator and its receptor: Cloning and induction by retinoic acid
1993
Review: Molecular pathogenesis of blood–brain barrier breakdown in acute brain injury
2010
Hematopoietic Stem Cell Development Is Dependent on Blood Flow
2009
Glycomics and glycoproteomics of membrane proteins and cell‐surface receptors: Present trends and future opportunities
2016
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Nanomaterials for In Vivo Imaging
2017
Targeting of drugs and nanoparticles to tumors
2010
Serpin Structure, Mechanism, and Function
2002 Standout
Genomic and Proteomic Profiling of Lung Cancers: Lung Cancer Classification in the Age of Targeted Therapy
2005
Phenotypic Heterogeneity of the Endothelium
2007
Tumor cell α3β1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis
2004
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Nanocarriers for Vascular Delivery of Anti-Inflammatory Agents
2014
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
1991
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Biomimetic amplification of nanoparticle homing to tumors
2007
Urokinase-type plasminogen activator and malignancy
1993
Nitric Oxide and Wound Healing
2004
Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro
2007
Adult hematopoietic stem cells lacking Hif-1α self-renew normally
2016 StandoutNobel
In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
1991
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Live-Cell Labeling of Specific Protein Glycoforms by Proximity-Enhanced Bioorthogonal Ligation
2015 StandoutNobel
Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.
1994
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.
1993
Targeted disruption of the even-skipped gene, evx1, causes early postimplantation lethality of the mouse conceptus.
1994 StandoutNobel
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
2015
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Identification of Transcription Complexes that Contain the Double Bromodomain Protein Brd2 and Chromatin Remodeling Machines
2006
Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial Cells
1994 Science
Requirement of Vascular Integrin α v β 3 for Angiogenesis
1994 StandoutScience
Matrix Metalloproteinases: A Review
1993 Standout
Subtractive immunization yields monoclonal antibodies that specifically inhibit metastasis
1993
Comparative Shotgun Proteomics Using Spectral Count Data and Quasi-Likelihood Modeling
2010
Regulation of the Ets-Related Transcription Factor Elf-1 by Binding to the Retinoblastoma Protein
1993 StandoutScienceNobel
Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion.
1993
Chemical Glycoproteomics
2016 StandoutNobel
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.
1992
Works of Jacqueline E. Testa being referenced
In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors
2014
The role of urokinase-type plasminogen activator in aggressive tumor cell behavior
1990
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung
2007
Urokinase‐type plasminogen activator biosynthesis is induced by the EJ‐Ha‐ras oncogene in CL26 mouse colon carcinoma cells
1989
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy
2004 Nature
Screening phage display libraries for organ-specific vascular immunotargeting in vivo
2005
Podokinesis in endothelial cell migration: role of nitric oxide
1998 Nobel
Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis.
1999
Molecular mechanisms involved in T cell activation. III. The role of extracellular calcium in antigen-induced lymphokine production and interleukin 2-induced proliferation of cloned cytotoxic T lymphocytes.
1988
Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2.
1992
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture
2004
Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1
1997